Claritev Corp

CTEV

Market cap $323M

MCLEAN, Va.--(BUSINESS WIRE)--Claritev Corporation ("Claritev" or the "Company") (NYSE: CTEV), a healthcare technology, data, and insights company focused on making healthcare more transparent and affordable, today announced two cornerstone philanthropic initiatives as a part of Claritev Cares™, a new charitable foundation. Applications are open for the Claritev Cares Rural Health Grant program until June 1, 2026. Since 1995, Claritev has contributed more than $700,000 to underserved communitie.

Claritev Corporation (CTEV) Discusses Business Outlook and Addresses Investor Questions Following Recent Quarter Transcript

MCLEAN, Va.--(BUSINESS WIRE)--Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced that members of its management team will meet with investors at the following investor events in March 2026: Mizuho Virtual Healthcare Technology Conference 2026 – Thursday, March 5, 2026 - 1x1 meetings hosted virtually Q&A Webcast Hosted by Nephron Research – Friday,.

MCLEAN, Va.--(BUSINESS WIRE)--Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, will host its 2026 Investor Day on Monday, March 16, 2026 at the New York Stock Exchange. The event will feature presentations by members of Claritev's management team discussing the company's long term growth strategy, vertical markets, product roadmap, and financial outlook, along with.

SAN DIEGO, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Claritev Corporation (NYSE: CTEV). The investigation focuses on Claritev's executive officers and whether investor losses may be recovered under federal securities laws.

Claritev Corporation (CTEV) Q4 2025 Earnings Call Prepared Remarks Transcript

Claritev Corporation (CTEV) came out with a quarterly loss of $4.88 per share versus the Zacks Consensus Estimate of a loss of $3.96. This compares to a loss of $5.14 per share a year ago.

MCLEAN, Va.--(BUSINESS WIRE)--Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today reported financial results for the fourth quarter and full year ended December 31, 2025. “I am exceedingly proud of the work delivered by the Claritev team in 2025. This year marked a pivotal time in our company's history, as we returned to top line revenue growth highlighted by op.

MCLEAN, Va--(BUSINESS WIRE)--Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a healthcare technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, announced today that it will release its fourth quarter and fiscal year 2025 financial results after market close on Monday, February 23, 2026, and hold a conference call at 4:30 pm Eastern Time. To join the conference call, please pre-register using the link below. Participant.

MCLEAN, Va.--(BUSINESS WIRE)--Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent, and fair for all, today announced a strategic relationship with Kinetiq Health, a healthcare risk management organization specializing in claims surveillance, diagnostic certainty, and cost intervention strategies. Rising medical and pharmacy costs are often driven by a small number of complex, high-cost.